Michael D Graf1, Denise F Needham2, Nicole Teed2, Trisha Brown2. 1. DNA Direct, Inc., 400 Buckwalter Place Boulevard, Bluffton, SC 29910, USA. mgraf@carecorenational.com. 2. DNA Direct, Inc., 400 Buckwalter Place Boulevard, Bluffton, SC 29910, USA.
Abstract
AIM: Health plan coverage policies can influence utilization of genetic tests. Our goal was to characterize the current state of test-related policies from US private payers. METHODS: We searched the public websites of 206 insurers for coverage policies. We documented the number of policies, tests mentioned, coverage determination and policy effective dates. RESULTS: Approximately one-third of insurers had at least one genetic testing policy. Moderate consistency was seen between payers. Tests in oncology and personalized medicine were most frequently addressed. Half of the policies specifically excluded coverage of a particular genetic service. Nearly half of insurers had at least one out-of-date policy. CONCLUSION: Genetic services are addressed by many large health plans. Challenges remain in ensuring consistency and currency of payer policy for genetic tests.
AIM: Health plan coverage policies can influence utilization of genetic tests. Our goal was to characterize the current state of test-related policies from US private payers. METHODS: We searched the public websites of 206 insurers for coverage policies. We documented the number of policies, tests mentioned, coverage determination and policy effective dates. RESULTS: Approximately one-third of insurers had at least one genetic testing policy. Moderate consistency was seen between payers. Tests in oncology and personalized medicine were most frequently addressed. Half of the policies specifically excluded coverage of a particular genetic service. Nearly half of insurers had at least one out-of-date policy. CONCLUSION: Genetic services are addressed by many large health plans. Challenges remain in ensuring consistency and currency of payer policy for genetic tests.
Authors: Ann Chen Wu; James P Kiley; Patricia J Noel; Shashi Amur; Esteban G Burchard; John P Clancy; Joshua Galanter; Maki Inada; Tiffanie K Jones; Jonathan A Kropski; James E Loyd; Lawrence M Nogee; Benjamin A Raby; Angela J Rogers; David A Schwartz; Don D Sin; Avrum Spira; Scott T Weiss; Lisa R Young; Blanca E Himes Journal: Am J Respir Crit Care Med Date: 2018-12-15 Impact factor: 21.405
Authors: Julia R Trosman; Christine B Weldon; Michael P Douglas; Allison W Kurian; R Kate Kelley; Patricia A Deverka; Kathryn A Phillips Journal: J Natl Compr Canc Netw Date: 2017-02-10 Impact factor: 11.908
Authors: Kathryn A Phillips; Patricia A Deverka; Julia R Trosman; Michael P Douglas; James D Chambers; Christine B Weldon; Andrew P Dervan Journal: Nat Biotechnol Date: 2017-07-12 Impact factor: 54.908
Authors: Julia R Trosman; Michael P Douglas; Su-Ying Liang; Christine B Weldon; Allison W Kurian; Robin K Kelley; Kathryn A Phillips Journal: Value Health Date: 2020-03-19 Impact factor: 5.725
Authors: Laura M Amendola; M Ragan Hart; Robin L Bennett; Martha Horike-Pyne; Michael Dorschner; Brian Shirts; Gail P Jarvik Journal: J Genet Couns Date: 2019-07-17 Impact factor: 2.537
Authors: Andrew P Dervan; Patricia A Deverka; Julia R Trosman; Christine B Weldon; Michael P Douglas; Kathryn A Phillips Journal: Genet Med Date: 2016-09-22 Impact factor: 8.822